4.5 Article

Diagnostic waste: whose responsibility?

Journal

GLOBALIZATION AND HEALTH
Volume 18, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12992-022-00823-7

Keywords

Diagnostics; Waste management; Sustainability; Responsibility; Product development

Funding

  1. European Research Council under European Union [715450]
  2. European Research Council (ERC) [715450] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Waste management is an important but often overlooked issue in discussions about improving diagnostic access in low- and middle-income countries (LMICs). The increase in diagnostic testing will result in a significant amount of diagnostic waste, posing threats to human and environmental health. Safe disposal of diagnostic waste should be integrated into the access agenda, and manufacturers should be held responsible for the entire life-cycle of their products.
Waste management is notably absent from current discussions about efforts to improve access to diagnostics in low-and middle-income Countries (LMICs). Yet an increase in testing will inevitably lead to an increase in diagnostic waste, especially since many of the diagnostic tests designed for use in LMICs are single-use point-of-care tests. Diagnostic waste poses a threat to both human and environmental health. In this commentary we draw on our experience of diagnostic waste management in Sierra Leone and review current evidence on: the volume and impact of diagnostic waste in LMICs, existing health-care waste management capacity in LMICs, established national and international policies for improving health-care waste management, and opportunities for strengthening policy in this area. We argue that questions of safe disposal for diagnostics should not be an afterthought, only posed once questions of access have already been addressed. Moreover, responsibility for safe disposal of diagnostic waste should not fall solely on national health systems by default. Instead, consideration of the end-life of diagnostic products must be fully integrated into the diagnostic access agenda and greater pressure should be placed on manufacturers to take responsibility for the full life-cycle of their products.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available